227 related articles for article (PubMed ID: 25217680)
1. Trends in high-dose opioid prescribing in Canada.
Gomes T; Mamdani MM; Paterson JM; Dhalla IA; Juurlink DN
Can Fam Physician; 2014 Sep; 60(9):826-32. PubMed ID: 25217680
[TBL] [Abstract][Full Text] [Related]
2. Trends and uptake of new formulations of controlled-release oxycodone in Canada.
Gomes T; Jain S; Paterson JM; Sketris I; Caetano P; Henry D;
Pharmacoepidemiol Drug Saf; 2018 May; 27(5):520-525. PubMed ID: 29359446
[TBL] [Abstract][Full Text] [Related]
3. Correlations between population-levels of prescription opioid dispensing and related deaths in Ontario (Canada), 2005-2016.
Fischer B; Jones W; Varatharajan T; Malta M; Kurdyak P
Prev Med; 2018 Nov; 116():112-118. PubMed ID: 30217407
[TBL] [Abstract][Full Text] [Related]
4. Patterns, Changes, and Trends in Prescription Opioid Dispensing in Canada, 2005-2016.
Fischer B; Jones W; Vojtila L; Kurdyak P
Pain Physician; 2018 May; 21(3):219-228. PubMed ID: 29871366
[TBL] [Abstract][Full Text] [Related]
5. Trends and changes in prescription opioid analgesic dispensing in Canada 2005-2012: an update with a focus on recent interventions.
Fischer B; Jones W; Rehm J
BMC Health Serv Res; 2014 Feb; 14():90. PubMed ID: 24572005
[TBL] [Abstract][Full Text] [Related]
6. Anticipating the effects of restricting high-dose preparations of strong opioids in Australia: A population-based analysis to inform the current policy debate.
Zheng D; Narayan SW; Zoega H; Litchfield M; Buckley NA; Pearson SA; Schaffer AL
Pharmacoepidemiol Drug Saf; 2019 Apr; 28(4):521-527. PubMed ID: 30790376
[TBL] [Abstract][Full Text] [Related]
7. State-to-State Variation in Opioid Dispensing Changes Following the Release of the 2016 CDC Guideline for Prescribing Opioids for Chronic Pain.
Lyu X; Guy GP; Baldwin GT; Losby JL; Bohnert ASB; Goldstick JE
JAMA Netw Open; 2023 Sep; 6(9):e2332507. PubMed ID: 37695587
[TBL] [Abstract][Full Text] [Related]
8. Trends and Patterns of Geographic Variation in Opioid Prescribing Practices by State, United States, 2006-2017.
Schieber LZ; Guy GP; Seth P; Young R; Mattson CL; Mikosz CA; Schieber RA
JAMA Netw Open; 2019 Mar; 2(3):e190665. PubMed ID: 30874783
[TBL] [Abstract][Full Text] [Related]
9. Trends in Opioid Prescribing and Dispensing by Veterinarians in Pennsylvania.
Clarke DL; Drobatz KJ; Korzekwa C; Nelson LS; Perrone J
JAMA Netw Open; 2019 Jan; 2(1):e186950. PubMed ID: 30646207
[TBL] [Abstract][Full Text] [Related]
10. Twenty-five years of prescription opioid use in Australia: a whole-of-population analysis using pharmaceutical claims.
Karanges EA; Blanch B; Buckley NA; Pearson SA
Br J Clin Pharmacol; 2016 Jul; 82(1):255-67. PubMed ID: 26991673
[TBL] [Abstract][Full Text] [Related]
11. Interprovincial variation in antibiotic use in Canada, 2019: a retrospective cross-sectional study.
Crosby M; von den Baumen TR; Chu C; Gomes T; Schwartz KL; Tadrous M
CMAJ Open; 2022; 10(1):E262-E268. PubMed ID: 35318250
[TBL] [Abstract][Full Text] [Related]
12. Patterns, trends and determinants of medical opioid utilization in Canada 2005-2020: characterizing an era of intensive rise and fall.
Jones W; Kaoser R; Fischer B
Subst Abuse Treat Prev Policy; 2021 Sep; 16(1):65. PubMed ID: 34521418
[TBL] [Abstract][Full Text] [Related]
13. Trends in dispensing of individual prescription opioid formulations, Canada 2005-2020.
Jones W; Kaoser R; Rudoler D; Fischer B
J Pharm Policy Pract; 2022 Mar; 15(1):27. PubMed ID: 35351208
[TBL] [Abstract][Full Text] [Related]
14. Changes in the dispensing of opioid medications in Canada following the introduction of a tamper-deterrent formulation of long-acting oxycodone: a time series analysis.
Gomes T; Mastorakos A; Paterson JM; Sketris I; Caetano P; Greaves S; Henry D;
CMAJ Open; 2017 Nov; 5(4):E800-E807. PubMed ID: 29167237
[TBL] [Abstract][Full Text] [Related]
15. Opioid and analgesic utilization in Ireland in 2000 and 2015: A repeated cross-sectional study.
Moriarty F; Bennett K; Fahey T
Pharmacol Res Perspect; 2022 Jan; 10(1):e00899. PubMed ID: 34913613
[TBL] [Abstract][Full Text] [Related]
16. Evaluating the early impacts of delisting high-strength opioids on patterns of prescribing in Ontario.
Guan Q; Khuu W; Martins D; Tadrous M; Chiu M; Do MT; Gomes T
Health Promot Chronic Dis Prev Can; 2018 Jun; 38(6):256-262. PubMed ID: 29911823
[TBL] [Abstract][Full Text] [Related]
17. Changes in opioid and other analgesic use 1995-2010: repeated cross-sectional analysis of dispensed prescribing for a large geographical population in Scotland.
Ruscitto A; Smith BH; Guthrie B
Eur J Pain; 2015 Jan; 19(1):59-66. PubMed ID: 24807782
[TBL] [Abstract][Full Text] [Related]
18. Examining correlations between opioid dispensing and opioid-related hospitalizations in Canada, 2007-2016.
Jones W; Kurdyak P; Fischer B
BMC Health Serv Res; 2020 Jul; 20(1):677. PubMed ID: 32698815
[TBL] [Abstract][Full Text] [Related]
19. Tramadol dispensing patterns and trends in Canada, 2007-2016.
Fischer B; Kurdyak P; Jones W
Pharmacoepidemiol Drug Saf; 2019 Mar; 28(3):396-400. PubMed ID: 30548353
[TBL] [Abstract][Full Text] [Related]
20. Geographical and socioeconomic disparities in opioid access in Mexico, 2015-19: a retrospective analysis of surveillance data.
Goodman-Meza D; Friedman J; Kalmin MM; Aguilar-Posada E; Seamans MJ; Velazquez-Moreno S; Fleiz C; Shin M; Arredondo-Sanchez J; Strathdee SA; Shoptaw S
Lancet Public Health; 2021 Feb; 6(2):e88-e96. PubMed ID: 33516291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
